Chaoyang Deyuan Pharmaceutical Co., Ltd.

This study aimed to study the pharmacokinetic characteristics of clopidogrel bisulfate tablets (75 mg) developed and produced by Liaoning Xinshanyuan Pharmaceutical Co., Ltd. after single oral administration on an empty stomach or after a meal; using clopidogrel bisulfate tablets (Plavix®, 75 mg) licensed and produced by Sanofi (Hangzhou) Pharmaceutical Co., Ltd. as the reference preparation, the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations were compared, and the bioequivalence of the two preparations in humans was evaluated.

This study aimed to investigate the pharmacokinetic characteristics of dapagliflozin tablets (10 mg) produced by Liaoning Xinshanyuan Pharmaceutical Co., Ltd. after single oral administration on an empty stomach or after a meal; using dapagliflozin tablets (Andatang®, 10 mg) produced by AstraZeneca Pharmaceuticals LP as the reference preparation, the pharmacokinetic parameters Cmax, AUC0-t, and AUC0-∞ of the two preparations were compared, and the bioequivalence of the two preparations in humans was evaluated.

The pharmacokinetics of the test tadalafil tablets 20 mg and the reference "Cialis®" 20 mg were studied in healthy subjects after oral administration on an empty stomach, and the bioequivalence of the test and reference tadalafil tablets was evaluated.